SINGER JAMES R 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-05 3:12 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | SINGER JAMES R | 3,000,000 4.700% | 150,000 (+5.26%) | Filing |
| 2020-03-27 08:56 am Purchase | 2020-03-17 | 13G | Ovid Therapeutics Inc. OVID | SINGER JAMES R | 2,850,000 5.200% | 495,000 (+21.02%) | Filing |